Nivolumab-Induced Exocrine Pancreatic Insufficiency

por Sweep, Boudewijn, Wilgenhof, Sofie, Anten, Sander
Publicado 2021

Overcoming HLA restriction in clinical trials: Immune monitoring of mRNA-loaded DC therapy

por Van Nuffel, An M.T., Wilgenhof, Sofie, Thielemans, Kris, Bonehill, Aude
Publicado 2012

Patterns of Response in Patients with Pretreated Metastatic Melanoma who Received Ipilimumab 3 mg/kg in a European Expanded Access Program: Five Illustrative Case Reports

por Wilgenhof, Sofie, Four, Stephanie Du, Everaert, Hendrik, Neyns, Bart
Publicado 2012

Phase II study of autologous mRNA electroporated dendritic cells (TriMixDC-MEL) in combination with Ipilimumab in patients with pretreated advanced melanoma

por Thielemans, Kris, Neyns, Bart, Wilgenhof, Sofie, Corthals, Jurgen, Heirman, Carlo
Publicado 2014

Clinical trials with MRNA electroporated dendritic cells for stage III/IV melanoma patients

por Wilgenhof, Sofie, Corthals, Jurgen, Heirman, Carlo, Neyns, Bart, Thielemans, Kris
Publicado 2015

Adoptive cellular therapies: the current landscape

por Rohaan, Maartje W., Wilgenhof, Sofie, Haanen, John B. A. G.
Publicado 2018

Characterization of CD8(+) T-Cell Responses in the Peripheral Blood and Skin Injection Sites of Melanoma Patients Treated with mRNA Electroporated Autologous Dendritic Cells (TriMi...

por Benteyn, Daphné, Van Nuffel, An M. T., Wilgenhof, Sofie, Corthals, Jurgen, Heirman, Carlo, Neyns, Bart, Thielemans, Kris, Bonehill, Aude
Publicado 2013

TriMix and tumor antigen mRNA electroporated dendritic cell vaccination plus ipilimumab: link between T-cell activation and clinical responses in advanced melanoma

por De Keersmaecker, Brenda, Claerhout, Sofie, Carrasco, Javier, Bar, Isabelle, Corthals, Jurgen, Wilgenhof, Sofie, Neyns, Bart, Thielemans, Kris
Publicado 2020

Exploring supportive care and information needs through a proposed eHealth application among melanoma patients undergoing systemic therapy: a qualitative study

por Fraterman, Itske, Glaser, Savannah L. C., Wilgenhof, Sofie, Medlock, Stephanie K., Mallo, Henk A., Cornet, Ronald, van de Poll-Franse, Lonneke V., Boekhout, Annelies H.
Publicado 2022

Quantitative assessment of BRAF V600 mutant circulating cell-free tumor DNA as a tool for therapeutic monitoring in metastatic melanoma patients treated with BRAF/MEK inhibitors

por Schreuer, Max, Meersseman, Geert, Van Den Herrewegen, Sari, Jansen, Yanina, Chevolet, Ines, Bott, Ambre, Wilgenhof, Sofie, Seremet, Teofila, Jacobs, Bart, Buyl, Ronald, Maertens, Geert, Neyns, Bart
Publicado 2016

Neoadjuvant nivolumab + T-VEC combination therapy for resectable early stage or metastatic (IIIB-IVM1a) melanoma with injectable disease: study protocol of the NIVEC trial

por Rohaan, Maartje W., Stahlie, Emma H. A., Franke, Viola, Zijlker, Lisanne P., Wilgenhof, Sofie, van der Noort, Vincent, van Akkooi, Alexander C. J., Haanen, John B. A. G.
Publicado 2022

Prophylactic Impella CP versus VA-ECMO in Patients Undergoing Complex High-Risk Indicated PCI

por van den Buijs, Deborah M. F., Wilgenhof, Adriaan, Knaapen, Paul, Zivelonghi, Carlo, Meijers, Tom, Vermeersch, Paul, Arslan, Fatih, Verouden, Niels, Nap, Alex, Sjauw, Krischan, van den Brink, Floris S.
Publicado 2022

Peripheral precocious puberty in Li–Fraumeni syndrome: a case report and literature review of pure androgen-secreting adrenocortical tumors

por Ryckx, Sofie, De Schepper, Jean, Giron, Philippe, Maes, Ken, Vaeyens, Freya, Wilgenhof, Kaat, Lefesvre, Pierre, Ernst, Caroline, Vanderlinden, Kim, Klink, Daniel, Hes, Frederik, Vanbesien, Jesse, Gies, Inge, Staels, Willem
Publicado 2023

Symptomatic Histologically Proven Necrosis of Brain following Stereotactic Radiation and Ipilimumab in Six Lesions in Four Melanoma Patients

por Du Four, Stephanie, Hong, Angela, Chan, Matthew, Charakidis, Michail, Duerinck, Johnny, Wilgenhof, Sofie, Wang, Wei, Feng, Linda, Michotte, Alex, Okera, Meena, Shivalingam, Brindha, Fogarty, Gerald, Kefford, Richard, Neyns, Bart
Publicado 2014

Molecular and epigenetic features of melanomas and tumor immune microenvironment linked to durable remission to ipilimumab-based immunotherapy in metastatic patients

por Seremet, Teofila, Koch, Alexander, Jansen, Yanina, Schreuer, Max, Wilgenhof, Sofie, Del Marmol, Véronique, Liènard, Danielle, Thielemans, Kris, Schats, Kelly, Kockx, Mark, Van Criekinge, Wim, Coulie, Pierre G., De Meyer, Tim, van Baren, Nicolas, Neyns, Bart
Publicado 2016

Primary Renal Tumour Response in Patients Treated with Nivolumab and Ipilimumab for Metastatic Renal Cell Carcinoma: Real-world Data Assessment

por Meerveld-Eggink, Aafke, Graafland, Niels, Wilgenhof, Sofie, Van Thienen, Johannes V., Lalezari, Ferry, Grant, Michael, Szabados, Bernadett, Abu-Ghanem, Yasmin, Kuusk, Teele, Boleti, Ekaterini, Blank, Christian U., Haanen, John B.A.G., Powles, Thomas, Bex, Axel
Publicado 2022

Indications and Outcomes for Deferred Cytoreductive Nephrectomy Following Immune Checkpoint Inhibitor Combination Therapy: Can Systemic Therapy be Withdrawn in Patients with No Evi...

por Fransen van de Putte, Elisabeth E., van den Brink, Luna, Mansour, Mohamed A., van der Mijn, Johannes C., Wilgenhof, Sofie, van Thienen, Johannes V., Haanen, John B.A.G., Boleti, Ekaterini, Powles, Thomas, Zondervan, Patricia J., Graafland, Niels M., Bex, Axel
Publicado 2023

An eHealth App (CAPABLE) Providing Symptom Monitoring, Well-Being Interventions, and Educational Material for Patients With Melanoma Treated With Immune Checkpoint Inhibitors: Prot...

por Fraterman, Itske, Wollersheim, Barbara M, Tibollo, Valentina, Glaser, Savannah Lucia Catherina, Medlock, Stephanie, Cornet, Ronald, Gabetta, Matteo, Gisko, Vitali, Barkan, Ella, di Flora, Nicola, Glasspool, David, Kogan, Alexandra, Lanzola, Giordano, Leizer, Roy, Mallo, Henk, Ottaviano, Manuel, Peleg, Mor, van de Poll-Franse, Lonneke V, Veggiotti, Nicole, Śniatała, Konrad, Wilk, Szymon, Parimbelli, Enea, Quaglini, Silvana, Rizzo, Mimma, Locati, Laura Deborah, Boekhout, Annelies, Sacchi, Lucia, Wilgenhof, Sofie
Publicado 2023

IMPemBra: a phase 2 study comparing pembrolizumab with intermittent/short-term dual MAPK pathway inhibition plus pembrolizumab in patients with melanoma harboring the BRAFV600 muta...

por Rozeman, Elisa A, Versluis, Judith M, Sikorska, Karolina, Hoefsmit, Esmée P, Dimitriadis, Petros, Rao, Disha, Lacroix, Ruben, Grijpink-Ongering, Lindsay G, Lopez-Yurda, Marta, Heeres, Birthe C, van de Wiel, Bart A, Flohil, Claudie, Sari, Aysegul, Heijmink, Stijn W T P J, van den Broek, Daan, Broeks, Annegien, de Groot, Jan Willem B, Vollebergh, Marieke A, Wilgenhof, Sofie, van Thienen, Johannes V, Haanen, John B A G, Blank, Christian U
Publicado 2023

Sex-Based Differences in Treatment with Immune Checkpoint Inhibition and Targeted Therapy for Advanced Melanoma: A Nationwide Cohort Study

por van der Kooij, Monique K., Dekkers, Olaf M., Aarts, Maureen J. B., van den Berkmortel, Franchette W. P. J., Boers-Sonderen, Marye J., de Groot, Jan Willem B., Hospers, Geke A. P., Piersma, Djura, van Rijn, Rozemarijn S., Suijkerbuijk, Karijn P. M., Westgeest, Hans M., van der Veldt, Astrid A. M., Vreugdenhil, Gerard, Wilgenhof, Sofie, Wouters, Michel W. J. M., Haanen, John B. A. G., van den Eertwegh, Alfonsus J. M., Kapiteijn, Ellen
Publicado 2021